Questions in Mild Asthma: An Official American Thoracic Society Research Statement

Background: Patients with mild asthma are believed to represent the majority of patients with asthma. Disease-associated risks such as exacerbations, lung function decline, and death have been understudied in this patient population. There have been no prior efforts from major societies to describe research needs in mild asthma. Methods: A multidisciplinary, diverse group of 24 international experts reviewed the literature, identified knowledge gaps, and provided research recommendations relating to mild asthma definition, pathophysiology, and management across all age groups. Research needs were also investigated from a patient perspective, generated in conjunction with patients with asthma, caregivers, and stakeholders. Of note, this project is not a systematic review of the evidence and is not a clinical practice guideline. Results: There are multiple unmet needs in research on mild asthma driven by large knowledge gaps in all areas. Specifically, there is an immediate need for a robust mild asthma definition and an improved understanding of its pathophysiology and management strategies across all age groups. Future research must factor in patient perspectives. Conclusions: Despite significant advances in severe asthma, there remain innumerable research areas requiring urgent attention in mild asthma. An important first step is to determine a better definition that will accurately reflect the heterogeneity and risks noted in this group. This research statement highlights the topics of research that are of the highest priority. Furthermore, it firmly advocates the need for engagement with patient groups and for more support for research in this field.

[1]  Trung Nghia Tran,et al.  Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study , 2022, Thorax.

[2]  C. Janson,et al.  The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study. , 2022, Respiratory medicine.

[3]  M. Idzko,et al.  European Respiratory Society guidelines for the diagnosis of asthma in adults , 2022, European Respiratory Journal.

[4]  C. Ambrose,et al.  Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study , 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.

[5]  I. Pavord,et al.  Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study , 2022, BMJ Open.

[6]  F. Albers,et al.  Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study. , 2021, Annals of Allergy, Asthma & Immunology.

[7]  G. Brusselle,et al.  The ALPACA study: (In)Appropriate LAMA Prescribing in Asthma: a Cohort Analysis. , 2021, Pulmonary pharmacology & therapeutics.

[8]  N. Hanania,et al.  Revisiting Mild Asthma: Current Knowledge and Future Needs. , 2021, Chest.

[9]  I. Pavord,et al.  Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide , 2021, Thorax.

[10]  R. Murray,et al.  Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities. , 2021, The journal of allergy and clinical immunology. In practice.

[11]  E. Serlachius,et al.  Targeting excessive avoidance behavior to reduce anxiety related to asthma: A feasibility study of an exposure-based treatment delivered online , 2021, Internet interventions.

[12]  M. Puu,et al.  Efficacy and safety of as-needed budesonide-formoterol in adolescents with mild asthma. , 2021, The journal of allergy and clinical immunology. In practice.

[13]  Todor A Popov,et al.  Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. , 2021, Chest.

[14]  I. Pavord,et al.  Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort , 2021, European Respiratory Journal.

[15]  C. Janson,et al.  Risk of re-hospitalization and death in patients hospitalized due to asthma. , 2020, The journal of allergy and clinical immunology. In practice.

[16]  D. Price,et al.  Potential severe asthma hidden in UK primary care. , 2020, The journal of allergy and clinical immunology. In practice.

[17]  Colin G. Walsh,et al.  2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group , 2020, The Journal of allergy and clinical immunology.

[18]  D. Roach,et al.  129Xe MRI as a measure of clinical disease severity for pediatric asthma. , 2020, The Journal of allergy and clinical immunology.

[19]  A. Leow,et al.  Impact of interventions targeting anxiety and depression in adults with asthma , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

[20]  I. Pavord,et al.  Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma , 2020, European Respiratory Journal.

[21]  I. Pavord,et al.  The burden of exacerbations in mild asthma: a systematic review , 2020, ERJ Open Research.

[22]  J. Malka-Rais,et al.  FeNO Response to Oral Corticosteroids in Children with Mild to Moderate Asthma: Influence of Race. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  Y. Hellsten,et al.  Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis , 2020, European Respiratory Journal.

[24]  Yuewei Liu,et al.  Recent trends in current asthma prevalence among US adults, 2009-2018. , 2020, The journal of allergy and clinical immunology. In practice.

[25]  N. Barnard,et al.  The role of nutrition in asthma prevention and treatment , 2020, Nutrition reviews.

[26]  M. Cabana,et al.  Heterogeneity of mild-to-moderate persistent asthma in children: Confirmation by latent class analysis and association with one-year outcomes. , 2020, The journal of allergy and clinical immunology. In practice.

[27]  Kathryn J. Sullivan,et al.  Structural and Social Determinants of Health in Asthma in Developed Economies: a Scoping Review of Literature Published Between 2014 and 2019 , 2020, Current Allergy and Asthma Reports.

[28]  C. Janson,et al.  Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme , 2020, European Respiratory Journal.

[29]  D. Price,et al.  Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey , 2019, BMJ Open.

[30]  A. Sheikh,et al.  GINA 2019: a fundamental change in asthma management , 2019, European Respiratory Journal.

[31]  M. Fletcher,et al.  A review of the burden and management of mild asthma in adults - Implications for clinical practice. , 2019, Respiratory medicine.

[32]  M. Schuers,et al.  Impact of non-drug therapies on asthma control: A systematic review of the literature , 2019, The European journal of general practice.

[33]  L. Lynd,et al.  Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression. , 2018, The journal of allergy and clinical immunology. In practice.

[34]  Gregory D. Kearney,et al.  Insights Into the Environmental Health Burden of Childhood Asthma , 2018, Environmental health insights.

[35]  P. O'Byrne,et al.  Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge. , 2017, The Journal of allergy and clinical immunology.

[36]  A. Ray,et al.  Neutrophilic Inflammation in Asthma and Association with Disease Severity. , 2017, Trends in immunology.

[37]  L. Wood,et al.  Diet and Asthma: Is It Time to Adapt Our Message? , 2017, Nutrients.

[38]  E. Israel,et al.  Race is associated with differences in airway inflammation in patients with asthma , 2017, The Journal of allergy and clinical immunology.

[39]  Todor A Popov,et al.  Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative. , 2017, The journal of allergy and clinical immunology. In practice.

[40]  E. Burchard,et al.  Perceived Discrimination Associated With Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies , 2017, Chest.

[41]  M. Dibonaventura,et al.  A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys , 2017, The Journal of asthma : official journal of the Association for the Care of Asthma.

[42]  M. Cabana,et al.  Individualized therapy for persistent asthma in young children. , 2016, The Journal of allergy and clinical immunology.

[43]  P. Gergen,et al.  Asthma phenotypes in inner-city children. , 2016, The Journal of allergy and clinical immunology.

[44]  S. Lam,et al.  Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study , 2015, Respiratory Research.

[45]  Ioannis Pandis,et al.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.

[46]  P. O'Byrne,et al.  T Helper 17 Cells and Related Cytokines after Allergen Inhalation Challenge in Allergic Asthmatics , 2014, International Archives of Allergy and Immunology.

[47]  N. Rabinovitch,et al.  Eczema and race as combined determinants for differential response to step-up asthma therapy. , 2014, The Journal of allergy and clinical immunology.

[48]  P. O'Byrne,et al.  Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[49]  Masatsugu Yamamoto,et al.  Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response , 2014, Allergy, Asthma & Clinical Immunology.

[50]  P. O'Byrne,et al.  Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma. , 2014, The Journal of allergy and clinical immunology.

[51]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[52]  K. Carlsen,et al.  Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction , 2013, Thorax.

[53]  Tonya S. King,et al.  Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. , 2012, JAMA.

[54]  L. Gerald,et al.  Feasibility of exercising adults with asthma: a randomized pilot study , 2012, Allergy, Asthma & Clinical Immunology.

[55]  J. Celedón,et al.  The Challenge of Asthma in Minority Populations , 2012, Clinical Reviews in Allergy & Immunology.

[56]  David M. Shade,et al.  Does age impact the obese asthma phenotype? Longitudinal asthma control, airway function, and airflow perception among mild persistent asthmatics. , 2011, Chest.

[57]  P. O'Byrne,et al.  Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. , 2010, The Journal of allergy and clinical immunology.

[58]  L. Boulet,et al.  Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma. , 2009, Respiratory medicine.

[59]  Clive Brown,et al.  Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. , 2009, Chest.

[60]  I. Pavord,et al.  A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.

[61]  C. Janson,et al.  Asthma mortality among Swedish children and young adults, a 10-year study. , 2008, Respiratory medicine.

[62]  E. Chen,et al.  Does the social environment contribute to asthma? , 2008, Immunology and allergy clinics of North America.

[63]  William W Busse,et al.  The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. , 2008, The Journal of allergy and clinical immunology.

[64]  D. Broide Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. , 2008, The Journal of allergy and clinical immunology.

[65]  D. Postma,et al.  Severe exacerbations predict excess lung function decline in asthma , 2007, European Respiratory Journal.

[66]  C. Delacourt,et al.  Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations , 2007, Allergy.

[67]  A. Wu,et al.  Are Physician Estimates of Asthma Severity Less Accurate in Black than in White Patients? , 2007, Journal of General Internal Medicine.

[68]  Sally E Wenzel,et al.  Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.

[69]  William W Busse,et al.  Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[70]  C. Jenkins,et al.  Double blind randomised controlled trial of two different breathing techniques in the management of asthma , 2006, Thorax.

[71]  M. Kraus-filarska,et al.  [Airway remodeling in asthma]. , 2006, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[72]  K. Chapman Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature. , 2005, Respiratory medicine.

[73]  D. Postma,et al.  Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. , 2005, The Journal of allergy and clinical immunology.

[74]  Rosalind Wright,et al.  Population disparities in asthma. , 2005, Annual review of public health.

[75]  S. Suissa,et al.  Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma , 2002, Thorax.

[76]  P. O'Byrne,et al.  Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. , 2002, American journal of respiratory and critical care medicine.

[77]  K. J. Macleod,et al.  Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.

[78]  A Tattersfield,et al.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.

[79]  R. Townley,et al.  The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. , 2001, The European respiratory journal.

[80]  L. Boulet,et al.  Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.

[81]  Inman,et al.  Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low‐dose allergen challenge in atopic asthmatics , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[82]  P. O'Byrne,et al.  Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[83]  L. Boulet,et al.  Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. , 1999, The European respiratory journal.

[84]  J. Bousquet,et al.  Airway inflammation in mild intermittent and in persistent asthma. , 1998, American journal of respiratory and critical care medicine.

[85]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.